Shorter Treatment Regimen For Drug-Resistant TB As Effective As Standard 2-Year Course, Study Shows

Health-e News: Shorter cure for resistant TB
“Drug-resistant tuberculosis (TB) can be cured in less than half the time, cutting costs and improving the chances that patients will complete the grueling treatment, according to a study published in the New England Journal of Medicine. Published on Wednesday night, the much-anticipated final results of the trial known as STREAM found that a nine- to 11-month treatment course is just as effective as the previous standard of 20 to 24 months of drugs in curing patients with multi-drug resistant TB (MDR-TB). This follows the December 2018 World Health Organization (WHO) recommendation for this shortened regimen, which, until now, was based on ‘very low certainty in the evidence’…” (Green, 3/14).

Additional coverage of the study results is available from Agence France-Presse and The Telegraph.